Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. - Test2 - elhamkhani - TriplyDB

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

http://www.wikidata.org/entity/Q34922621

about

Mild Neurocognitive Disorder: An Old Wine in a New Bottle Primate aging in the mammalian scheme: the puzzle of extreme variation in brain aging Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals At the interface of sensory and motor dysfunctions and Alzheimer's disease.Neuropathological alterations in Alzheimer disease Large-scale brain networks of the human left temporal pole: a functional connectivity MRI study.Naming impairment in Alzheimer's disease is associated with left anterior temporal lobe atrophy Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Using structural and diffusion magnetic resonance imaging to differentiate the dementias.Data-driven regions of interest for longitudinal change in frontotemporal lobar degeneration.Data-driven regions of interest for longitudinal change in three variants of frontotemporal lobar degeneration.Brain region's relative proximity as marker for Alzheimer's disease based on structural MRI.Parahippocampal white matter volume predicts Alzheimer's disease risk in cognitively normal old adults An expanded role for neuroimaging in the evaluation of memory impairment.The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition Vascular risk and Aβ interact to reduce cortical thickness in AD vulnerable brain regions.Structural imaging in early pre-states of dementia.Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.Current status and future perspectives of magnetic resonance high-field imaging: a summary Functional MRI of mnemonic networks across the spectrum of normal aging, mild cognitive impairment, and Alzheimer's disease Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.A review of neuroimaging biomarkers of Alzheimer's disease.Internet-based screening for dementia risk.Microstructural white matter changes, not hippocampal atrophy, detect early amnestic mild cognitive impairment.Integrated cortical structural marker for Alzheimer's disease.Medial temporal cortices in ex vivo magnetic resonance imaging.Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.Decreased white matter integrity in neuropsychologically defined mild cognitive impairment is independent of cortical thinning.Imaging biomarkers associated with cognitive decline: a review.Participation in cognitively-stimulating activities is associated with brain structure and cognitive function in preclinical Alzheimer's disease.Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults.Mapping the Relationship of Contributing Factors for Preclinical Alzheimer's Disease.Tracking cognitive change over 24 weeks with longitudinal functional magnetic resonance imaging in Alzheimer's disease.Evidence for ordering of Alzheimer disease biomarkers Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.Absence of practice effects in preclinical Alzheimer's disease.MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.Is the Alzheimer's disease cortical thickness signature a biological marker for memory?Combining structural brain changes improves the prediction of Alzheimer's disease and mild cognitive impairment.

P2860

Q26786539-BBD0C477-7292-4BB6-AF56-6E0699986CFC Q26865145-9872C6DB-D4B1-4050-A7EE-6DECDEA73F02 Q26995405-6D3C1FB9-8197-49E5-B35E-ABE831A5FDA6 Q27000410-857E571E-4DAE-46E2-A8C9-D5C2288AD120 Q27003314-8617020B-96E5-4FEF-893B-8D58BC466DD3 Q27303119-0BD6B5C8-5763-4E12-AB30-B042BC42C692 Q28686824-E8752B8A-517E-402E-9527-0204D8613745 Q30239789-F7933BBD-584F-43EC-B33A-D2463DA6E47E Q30836806-BA14E209-24E3-4250-B388-8FEFDE81686D Q31122791-951A7048-6154-4452-95FE-62AA5817EB5C Q33562216-577FA5AB-92BC-4B7F-9999-53FC54498EC1 Q33722365-415CE4D6-8DA5-4B70-8D4E-CC9DCE105A0C Q33800195-4A34B4D4-73AD-4D93-BA69-508725046EC4 Q33830698-E5687072-45F9-43A0-8919-EA1D9AB6F63B Q33902744-EE39CF38-FB0C-46B2-AE20-C43BD9C1172D Q33965410-10E5E1B3-C97B-4081-8A05-C7FE6ACFF798 Q33967561-40C56D9C-5325-495E-82E8-E6D14FD5C0E1 Q34252876-9C52540D-B921-40F1-8672-2E1EC8E42EB4 Q34253039-46711E0C-24C2-4617-8BE9-9EDA54D20A8E Q34378779-820B97B1-8B75-459D-BC88-F62A7C7DF35C Q34498348-2962C3B0-C15A-4193-90B9-BEC73BD405B8 Q34571189-D7EEC160-2858-4524-993A-158ABAF0C70A Q34600572-F3BC9C60-7457-4ED1-874C-3460129DF224 Q34630119-91CF29F4-AE17-424B-ADD8-4BFE2623BFB3 Q34715688-70315A45-C8A7-401A-9194-52D2AEB758DC Q34861994-4BC56E42-886E-4157-8A49-241F8CDB9B1C Q35019559-E4A46CCA-E14C-4615-9C07-9132F88E7908 Q35167339-F3982CA0-22FF-49A7-BC5C-75CBED5DD7CD Q35185786-641AF3EA-4E97-4774-95EE-C704FC7FE9B9 Q35561896-2E312E5C-99E8-408A-AED9-8B44E21DC112 Q35787932-F11B0168-686C-4E41-83F6-3EDA1C1B8BAF Q35865377-99811411-B913-4AF2-A1AC-29EF8F17365F Q36013947-6A92DAE9-40FE-4AEE-89DA-F55E661AD3E1 Q36071403-F0F45837-256F-4D03-95EA-56794BEF77C8 Q36143793-26C47D86-324A-4DE6-8F79-0F9506E027C9 Q36269046-70EF5C8A-509A-4DDF-84B1-1936A371F63F Q36304533-0C474A42-72B1-43AC-88CC-D419F7320850 Q36348208-0F2AEEBA-DF09-4E84-BD02-630C5A0ECD0C Q36348325-ECBBF194-49F9-4368-B6DB-5945BC02DA26 Q36374662-9E3AED94-0410-4B64-AF30-624180485823

P2860

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

http://www.wikidata.org/entity/Q34922621

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@ast

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@en

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@nl

type

label

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@ast

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@en

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@nl

prefLabel

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@ast

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@en

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@nl

P1433

Q34922621-7A7F8563-8AD1-4F48-A707-67496EB579DA

P1476

Q34922621-291F5BA3-FC6F-4C02-9630-A63A76DE1B65

P2093

Q34922621-33102702-C48F-4949-98E9-D0DB7A765CC7

Q34922621-382E16D2-D8A4-4BED-A67E-95C882A37743

Q34922621-61B7D816-139B-41B5-B7B9-560F82CDD2D3

Q34922621-77FBA6E8-12A4-4550-90B9-5477DC12D20C

Q34922621-88076654-150F-4DD4-87D2-85CFC404A5AB

Q34922621-9C9A23FD-31B2-4738-B7DA-CE404D0CCC41

Q34922621-A1B4A866-DC2E-4215-8196-6368F0FD8900

Q34922621-A6F31FB0-8EE0-44AF-98D8-59ABF7D20E01

Q34922621-FCA94942-9707-4E24-A64D-EE5624FEAFA2

P2860

Q34922621-05D9A6A6-872A-4644-AAAE-05A357E6C0D0

Q34922621-0CF8B9DD-B52F-4233-A15D-A31E8AB56AEE

Q34922621-14DAC2B9-EB2B-4099-A4F7-40E770D528A8

Q34922621-168E51FA-A486-4260-8762-82B97F168F67

Q34922621-21821BD7-493A-43E2-B512-3A9F1FF2C2AA

Q34922621-2AACB73C-6DB0-4AAD-B934-30B205F554D0

Q34922621-2C9BBE4E-A14D-4C04-9251-237930213A8C

Q34922621-34205B19-376F-47FC-8449-0AE364106464

Q34922621-39CF5F57-1C2F-4D16-A131-C2F1DC64DF4B

Q34922621-3DB9176D-53C7-4C48-A035-5EE0E2050C77

P304

Q34922621-2E042B73-4144-41BB-A93F-2F9B153F4423

P31

Q34922621-806CFCC0-B093-4A96-93C2-72009657E9C4

P356

Q34922621-1BE073F4-7F89-44B4-B6EF-D6D359AF8BE4

P407

Q34922621-32865AC6-877A-4631-97A2-65C433575B3A

P433

Q34922621-DDE29E1A-3CF1-4458-B146-73B76554CDEA

P478

Q34922621-9781C16F-CC06-4ADF-971F-F4C37FB283F3

P577

Q34922621-305F2C4F-A291-4FCA-A2A0-E049DCEE6172

P698

Q34922621-3F4AD040-A83E-4D9F-A6F5-7FD66F1072EB

P921

Q34922621-296D0D8E-BBA1-47FF-8B9D-757B2D97E303

Q34922621-5F4963E6-9761-4EDB-BD3C-DC552D22C589

Q34922621-CDBF3559-99E8-46D9-A816-86A8FE7BF84C

P932

Q34922621-A9C39721-71C3-47CE-AFD8-BFE4A019B04F

P356

WNL.0B013E3182166E96

P1433

P1476

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults.

@en

P2093

B C Dickerson

http://www.w3.org/2001/XMLSchema#string

B T Hyman

http://www.w3.org/2001/XMLSchema#string

D Blacker

http://www.w3.org/2001/XMLSchema#string

L Detoledo-Morrell

http://www.w3.org/2001/XMLSchema#string

M S Albert

http://www.w3.org/2001/XMLSchema#string

R A Sperling

http://www.w3.org/2001/XMLSchema#string

R C Shah

http://www.w3.org/2001/XMLSchema#string

R J Killiany

http://www.w3.org/2001/XMLSchema#string

T R Stoub

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake

Neuropathological stageing of Alzheimer-related changes

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease

Evidence that volume of anterior medial temporal lobe is reduced in seniors destined for mild cognitive impairment.

Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal.

Cognitive reserve and Alzheimer disease.

Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls

P304

1395-1402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0B013E3182166E96

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21490323

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3087406

http://www.w3.org/2001/XMLSchema#string